Focal segmental glomerulosclerosis (FSGS) is one of the primary glomerular disorders in both children and adults which can progress to end-stage renal failure. Recent advances in cell biology and genetics have found new molecules and signaling mechanisms in podocytes for the pathogenesis of FSGS. Understanding of the genetics, animal models, immunology, and treatments of FSGS will lead to the better patient outcome. We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the various aspects of FSGS, including recent advances in podocyte biology, molecular genetics, pathology, immunology, animal models, treatment trials, and potential therapeutic strategies.

Potential topics include, but are not limited to:

• Advances in molecular genetics of podocytes in FSGS
• Advances in immunology in FSGS
• Relevance of various FSGS animal models
• Pathologic classifications in FSGS
• Recent advances in treatments of FSGS
• Recurrent FSGS after renal transplantation